Table 5 Pathway Enrichment analysis of differentially expressed proteins relative to EFL1 compared with control
NO. | Maps | pValue |
|---|---|---|
1 | Development_Angiopoietin - Tie2 signaling | 0.000027 |
2 | Immune response_IL-7 signaling in T lymphocytes | 0.000035 |
3 | Immune response_IL-7 signaling in B lymphocytes | 0.000051 |
4 | Immune response_Antiviral actions of Interferons | 0.000090 |
5 | Immune response_Oncostatin M signaling via JAK-Stat in mouse cells | 0.000425 |
6 | Immune response_Oncostatin M signaling via JAK-Stat in human cells | 0.000526 |
7 | Development_Thrombopoetin signaling via JAK-STAT pathway | 0.000639 |
8 | Immune response_IL-15 signaling via JAK-STAT cascade | 0.000699 |
9 | Immune response_IL-23 signaling pathway | 0.000827 |
10 | Signal transduction_PTMs in IL-23 signaling pathway | 0.001274 |
11 | Development_PDGF signaling via STATs and NF-kB | 0.001357 |
12 | Immune response_IL-22 signaling pathway | 0.001532 |
13 | Development_EPO-induced Jak-STAT pathway | 0.001623 |
14 | Development_Growth hormone signaling via STATs and PLC/IP3 | 0.001623 |
15 | Immune response_IL-9 signaling pathway | 0.001717 |